Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer-Reference-Cited by-同舟云学术

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

Published:2020-02-17 Issue:4 Volume:1 Page:423-436
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Stewart C. Allison,Gay Carl M.,Xi Yuanxin,Sivajothi Santhosh,Sivakamasundari V.,Fujimoto Junya,Bolisetty Mohan,Hartsfield Patrice M.,Balasubramaniyan Veerakumar,Chalishazar Milind D.,Moran Cesar,Kalhor Neda,Stewart John,Tran Hai,Swisher Stephen G.,Roth Jack A.,Zhang Jianjun,de Groot John,Glisson Bonnie,Oliver Trudy G.^ORCID,Heymach John V.,Wistuba Ignacio,Robson Paul^ORCID,Wang Jing,Byers Lauren Averett^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s43018-019-0020-z.pdf

Reference55 articles.

1. Horn, L. et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N. Engl. J. Med. 379, 2220–2229 (2018).

2. H.R.733: Leech Lake Band of Ojibwe Reservation Restoration Act (Senate and House of Representatives of the United States of America in Congress, 2012). https://www.congress.gov/bill/112th-congress/house-bill/733

3. Hodgkinson, C. L. et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat. Med. 20, 897–903 (2014).

4. Drapkin, B. J. et al. Genomic and functional fidelity of small cell lung cancer patient-derived xenografts. Cancer Discov. 8, 600–615 (2018).

5. Chalishazar, M. D. et al. MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion. Clin. Cancer Res. 25, 5107–5121 (2019).

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer;Molecular Therapy - Nucleic Acids;2024-09

2. DrugFormer: Graph‐Enhanced Language Model to Predict Drug Sensitivity;Advanced Science;2024-08-29

3. DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models;Journal of Translational Medicine;2024-08-14

4. Pathologie, Molekularpathologie und künstliche Intelligenz beim kleinzelligen Lungenkarzinom;Die Onkologie;2024-08-07

5. GCN2 is a determinant of the response to WEE1 kinase inhibition in small-cell lung cancer;Cell Reports;2024-08